Scientific diligence for better preclinical decisions.
Independent assessment of therapeutic assets—clarifying scientific credibility, critical risks and the evidence needed to move forward.
THE PRECLINICAL INTELLIGENCE ASSESSMENT
Know what the evidence supports.
The PIA turns complex preclinical evidence into a clear development decision.
Scientific credibility. Critical risks. Decisive next experiments.
A decision report with a PIA Score, confidence level and capital gate.
PUBLIC DEMONSTRATION CASE
See the assessment in practice.
Start with the five-page sample brief for a quick overview of the PRT13722 HOLD decision. Explore the full demonstration assessment for the scientific evidence and reasoning.
PIA Score: 63/100 | Decision: HOLD | Confidence: Moderate
PRT13722 · Sample Brief · Public Demonstration
WHO WE WORK WITH
For teams facing a consequential next step.
Biotech founders
Prioritize the evidence that should come next.
Investors & funds
Test the thesis before committing capital.
Research & spinout teams
Clarify translational readiness.
Technology transfer
Assess scientific differentiation and risk.
Incubators & accelerators
Focus support on decision-critical evidence.
Licensing & partnering teams
Identify what diligence must resolve.